Studies related to Neutrophil Activity and N-Acetylcysteine

Induced Sputum Of Patients With Chronic Obstructive Pulmonary Disease (COPD) Contains Adhesion-promoting, Therapy-sensitive Factors

Effect Decrease
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 50
Sex Both Genders
Age Range 45-64, 65+
Body Types Average
Notes for this study:
In sputum collected from the lungs of persons with COPD, ten months of supplementation (but not eight weeks) of 600mg N-acetylcysteine appeared to reduce the activation and adhesion of neutrophils to tissue, suggesting a mucolytic effect in the lungs.